iShares MSCI Malaysia ETF vs Medtronic PLC — how do they compare? iShares MSCI Malaysia ETF trades at $27.97, while Medtronic PLC trades at $82.97 (market cap $103.01B). The key difference: Medtronic PLC pays a 3.58% dividend while iShares MSCI Malaysia ETF pays none, and iShares MSCI Malaysia ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| EWM | MDT | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $30.42 | $105.35 |
52-Week Low | $23.49 | $73.75 |
Market Cap | — | $103.01B |
Enterprise Value | — | $121.75B |
Dividend Yield | — | 3.58% |
Signals from Pluang's Aura AI — not financial advice
EWM (iShares MSCI Malaysia ETF) trades at $28.005, down 0.3% on the day, with technical indicators showing a bullish bias despite overbought RSI readings. The ETF provides concentrated exposure to Malaysia's financial (54%) and industrial (21%) sectors, benefiting from the country's data center expansion, semiconductor ambitions, and tourism initiatives. Recent news highlights Malaysia's energy diversification efforts amid regional power demand surges.
The outlook remains constructive given Malaysia's structural growth drivers, though investors face currency risk, regional geopolitical tensions, and dependence on global semiconductor demand. Current technical strength suggests near-term upside potential, but elevated RSI levels warrant caution for entry timing.
Medtronic (MDT) trades at $83.19, up 4.91% over the past 24 hours, with a technical outlook that is bearish based on moving averages but supported by neutral oscillators. The stock has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $1.55 surpassing the $1.54 estimate. Revenue grew to $33.54 billion in 2025, and the company maintains strong profitability with a net income margin of 13.2%. Recent corporate actions include a $0.72 dividend payment scheduled for July 2026.
The outlook for MDT is positive, supported by robust fundamentals, a favorable analyst consensus with a $97.50 price target, and a dividend aristocrat status. Key risks include increasing debt levels and competitive pressures in the medical device sector. The stock presents a long-term opportunity for growth and income, though near-term technical weakness may persist.
Trailing returns across standard periods
Latest headlines on both assets
EWM tracks the MSCI Malaysia Index, providing exposure to the Malaysian equity market. It offers a diversified portfolio of large and mid-sized companies across various sectors in Malaysia.
Read more on EWM →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →